sources: 15203
Data license: CC-BY
This data as json
id | name | description | createdAt | updatedAt | datasetId | additionalInfo | link | dataPublishedBy |
---|---|---|---|---|---|---|---|---|
15203 | Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | { "link": "http://apps.who.int/gho/data/node.home", "retrievedDate": "23-March-18", "additionalInfo": "Indicator name\nNumber of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission\n\nName abbreviated\n\n \n\nData Type Representation\nCount\n\nTopic\n\n \n\nISO Health Indicators Framework\nAccessibility\n\nRationale\nThe risk for mother-to-child transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding.\nThe data will be used to track progress toward global and national goals towards elimination of mothert-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up.\n\nDefinition\nNumber of HIV-positive pregnant women who received antiretroviral drugs\nduring the past 12 months to reduce mother-to-child transmission.\n\nAssociated terms\n\n \n\nPreferred data sources\n\n \n\nOther possible data sources\n\n \n\nMethod of measurement\n\n \n\nMethod of estimation\nProgramme monitoring: facility-based antiretroviral therapy registers or drug supply management systems.\n\nM&E Framework\n\n \n\nMethod of estimation of global and regional aggregates\n\n \n\nDisaggregation\n\n \n\nUnit of Measure\n\n \n\nUnit Multiplier\n\n \n\nExpected frequency of data dissemination\n\n \n\nExpected frequency of data collection\n\n \n\nLimitations\n\n \n\nLinks\n\n \n\nComments\n\n \n\nContact Person\n\n \n\n", "dataPublishedBy": "World Health Organization Global Health Observatory (GHO)", "dataPublisherSource": null } |
2018-03-23 12:43:50 | 2018-03-23 12:43:50 | 2694 | Indicator name Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission Name abbreviated Data Type Representation Count Topic ISO Health Indicators Framework Accessibility Rationale The risk for mother-to-child transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding. The data will be used to track progress toward global and national goals towards elimination of mothert-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up. Definition Number of HIV-positive pregnant women who received antiretroviral drugs during the past 12 months to reduce mother-to-child transmission. Associated terms Preferred data sources Other possible data sources Method of measurement Method of estimation Programme monitoring: facility-based antiretroviral therapy registers or drug supply management systems. M&E Framework Method of estimation of global and regional aggregates Disaggregation Unit of Measure Unit Multiplier Expected frequency of data dissemination Expected frequency of data collection Limitations Links Comments Contact Person | http://apps.who.int/gho/data/node.home | World Health Organization Global Health Observatory (GHO) |
Links from other tables
- 1 row from sourceId in variables